Acute Lymphocytic Leukemia (ALL) Completed Phase 2 Trials for Fludarabine (DB01073)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

IndicationStatusPhase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02294552Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCTTreatment
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesTreatment
NCT00145626HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesTreatment